Salvage of Infected Cardiovascular Implantable Electronic Devices (CIED) by Localized High-dose Antibiotics

Hillel Yaffe Medical Center100 enrolled

Overview

Following previous positive experience with regulated CITA-RNPT of infected CIEDs, we suggest increasing the number of recruited patients and that CITA-RNPT can be administered prophylactically to patients prior to replacement of previously treated CIEDs, immuno-compromised patients, and others.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

100

Conditions

Infection

Interventions

CITA-RNPTDRUG

Extraction of infected CIEDPROCEDURE

Eligibility

Sex: ALLMin age: 15 Years

Medical Language ↔ Plain English

Inclusion Criteria: * High-risk patients for CIED infections * CIED infections Exclusion Criteria: * Systematic infection

Locations (1)

Tel Aviv Medical Center

Tel Aviv, Israel

RECRUITING

Outcomes

Primary Outcomes

Lack of CIED Infection

Time frame: One year

Central Contacts

Moris Topaz, MD, PhD

CONTACT

972505251122 topazmd@netvision.net.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.